Cameron Smith is a partner in FB Rice’s Melbourne biotechnology team, specialising in global market exclusivity strategies for innovative biotechnology products. His expertise spans biological therapeutics, including cell and gene therapies, precision medicines, CAR T-cells, antibodies, and mRNA therapeutics.

Cameron advises a diverse range of clients, from publicly listed companies to early-stage ventures and university commercialisation teams. He has extensive experience in international patent portfolio management, due diligence, patent landscape analysis, and patent oppositions in Australia and New Zealand.

His strategic approach to intellectual property has supported successful capital raising and commercialisation efforts, including IPOs, venture debt, and partnerships with global pharmaceutical and biotech companies.